BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1834876)

  • 1. [Correlations among FPB beta 15-42, PAC and D-dimer].
    Gando S; Tedo I
    Rinsho Byori; 1991 Sep; 39(9):972-6. PubMed ID: 1834876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic molecular markers before the onset of disseminated intravascular coagulation.
    Wada H; Sakuragawa N; Mori Y; Takagi M; Nakasaki T; Shimura M; Hiyoyama K; Nisikawa M; Gabazza EC; Deguchi K; Kazama M; Shiku H
    Am J Hematol; 1999 Apr; 60(4):273-8. PubMed ID: 10203100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttrauma coagulation and fibrinolysis.
    Gando S; Tedo I; Kubota M
    Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].
    Gando S; Tedo I
    Rinsho Ketsueki; 1990 Nov; 31(11):1774-9. PubMed ID: 2149574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H; Gabazza E; Nakasaki T; Shimura M; Hiyoyama K; Deguchi K; Nishikawa M; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 2000; 26(1):17-21. PubMed ID: 10805276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T; Aoki N
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
    Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
    Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma alpha 2-plasmin inhibitor-plasmin complex and FDP-D-Dimer in fulminant hepatic failure.
    Tomiya T; Hayashi S; Ogata I; Fujiwara K
    Thromb Res; 1989 Feb; 53(3):253-60. PubMed ID: 2524118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Shibata A
    Am J Hematol; 1991 Apr; 36(4):255-8. PubMed ID: 1826408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of tissue factor-like activity in plasma of patients with DIC.
    Iijima K; Fukuda C; Nakamura K
    Thromb Res; 1991 Jan; 61(1):29-38. PubMed ID: 1826974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
    Marongiu F; Conti M; Mameli G; Sorano GG; Cossu E; Cirillo R; Balestrieri A
    Thromb Res; 1990 Apr; 58(2):91-9. PubMed ID: 1693451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
    Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
    Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.